Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation [Phase 2]
Phase 2 trial results evaluate the efficacy and safety of AZD7009 in patients with atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2007-11-26Clinical Trial Update: FFS - Far Field Sensing Test Study in Cardiac Dual Chamber Pacemakers [Phase 4]
The document reports the completion of a Phase 4 clinical trial (Far Field Sensing Test Study) in dual-chamber cardiac pacemakers for atrial…
-
FDA approval · 2007-11-16FDA Approved: PACERONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for PACERONE (amiodarone hydrochloride) from Upsher-Smith Laboratories, LLC. The action modifies/exp…
-
CLINICAL_TRIALS trial_result · 2007-11-08Clinical Trial Update: Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation [Phase 2]
This clinical trial update reports the completion of a Phase 2 study of a new anticoagulant drug in patients with atrial fibrillation. Spons…
-
FDA approval · 2007-11-07FDA Approved: FLECAINIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for flecainide acetate from Hikma Pharmaceuticals USA Inc., approving changes to the approved generi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-10-30FDA Approved: DIGOXIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Digoxin under an original ANDA, allowing generic Digoxin from Hikma Pharmaceuticals USA Inc. to be marketed.
-
FDA approval · 2007-10-22FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for amiodarone hydrochloride (ANDA 075761) to support its manufacture by Fresenius Kabi USA, LLC.
-
FDA label_change · 2007-10-18FDA Approved: TIKOSYN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TIKOSYN (dofetilide) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2007-10-15FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for amiodarone hydrochloride submitted by Mylan Institutional LLC.
-
FDA approval · 2007-07-11FDA Approved: WARFARIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Warfarin Sodium from Teva Pharmaceuticals USA, Inc. for the generic product under the ANDA.
-
CLINICAL_TRIALS trial_result · 2007-06-25Clinical Trial Update: Safety and Efficacy Study of RENEWAL 4 AVT [Phase 2, Phase 3]
Phase 2/3 safety and efficacy study of the RENEWAL 4 AVT has completed.
-
FDA approval · 2007-06-21FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for propranolol hydrochloride (generic) from Hikma Pharmaceuticals USA Inc., indicating an approval …
-
FDA approval · 2007-06-14FDA Approved: DIGOXIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Digoxin from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS research · 2007-06-11Clinical Trial Update: Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing [NA]
This clinical trial update discusses modeling genotype and other factors to improve the safety of warfarin (Coumadin) prescribing. It covers…
-
FDA approval · 2007-05-11FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for CARTIA XT (diltiazem hydrochloride) from Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2007-05-10Clinical Trial Update: Follow-up Study of the RAI-Treated Hyperthyroid Patients
This update summarizes the follow-up results from a completed trial of hyperthyroid patients treated with radioactive iodine, highlighting c…
-
FDA approval · 2007-04-27FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) from Bausch Health US LLC.
-
CLINICAL_TRIALS research · 2007-04-20Clinical Trial Update: Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation
The update discusses whether biological markers can predict recurrence of atrial fibrillation after radiofrequency catheter ablation.
-
FDA approval · 2007-04-19FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for verapamil hydrochloride from Actavis Pharma, Inc., granting approval of a supplemental indicatio…
-
CLINICAL_TRIALS research · 2007-04-19Clinical Trial Update: Atrial Fibrillation and the Risk for Neurological Complications
This clinical trial update examines whether atrial fibrillation is associated with an increased risk of neurological complications. The curr…
-
FDA approval · 2007-04-12FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Labratories Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2007-04-12FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Verapamil Hydrochloride from Actavis Pharma, Inc., confirming regulatory approval of an upda…
-
FDA approval · 2007-04-12FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride from Actavis Pharma, Inc., updating the approval status for this generic…
-
FDA approval · 2007-04-11FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for amiodarone hydrochloride (generic) submitted by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2007-03-22Clinical Trial Update: Continuous Versus Episodic Amiodarone Treatment for the Prevention of Permanent Atrial Fibrillation [NA]
A completed clinical trial comparing continuous versus episodic amiodarone treatment for the prevention of permanent atrial fibrillation.